果糖代谢与麻醉/手术诱导的乳酸生成相关
本研究纳入43例≥60岁全麻手术患者,并采用20月龄小鼠模型,探讨果糖代谢与术后延迟神经认知恢复(dNCR)的关联。代谢组学显示dNCR患者术后血清果糖1-磷酸显著降低,小鼠脑内结果类似;同位素标记显示果糖而非葡萄糖进入糖酵解增加脑乳酸,果糖抑制剂可抑制乳酸升高并改善认知功能障碍。
要点
- 术后dNCR患者血清果糖1-磷酸水平显著低于非dNCR患者。
- 麻醉/手术激活果糖代谢,果糖(而非葡萄糖)进入糖酵解增加脑乳酸。
- 果糖代谢抑制剂可抑制脑乳酸升高并改善术后认知功能障碍。
核心结论
- 麻醉/手术激活果糖代谢,产生过量脑乳酸,与术后认知功能障碍相关。
- 果糖代谢是dNCR的潜在治疗靶点。
研究设计与样本
- 纳入43例≥60岁全麻手术患者,术后评估dNCR。
- 采用20月龄小鼠暴露于七氟烷诱导术后dNCR,对照组暴露于40%氧气。
- 小鼠侧脑室注射果糖或葡萄糖,或腹腔注射果糖代谢抑制剂。
- 使用Barnes迷宫和Y迷宫评估小鼠认知功能。
- 代谢组学检测患者血清和小鼠脑组织代谢物,同位素标记和代谢流分析代谢途径。
主要发现
- 43例患者中17例发生dNCR。
- dNCR患者术后血清果糖1-磷酸水平较非dNCR患者显著降低(均数差[×10^4] = -0.164 ± 0.070;P = .024)。
- 小鼠脑内果糖1-磷酸水平结果类似(均数差 = -1.669 ± 0.555;P = .014)。
- 小鼠同位素标记和代谢流实验显示果糖而非葡萄糖进入糖酵解,麻醉/手术后脑乳酸水平升高(P < .05)。
- 腹腔注射果糖抑制剂可抑制小鼠脑乳酸升高(均数差 = 96.0 ± 4.36,P = .0237)并改善术后认知功能障碍(均数差 = 69.0 ± 3.94,P = .0237)。
临床怎么用
- 果糖代谢通路可能作为术后认知功能障碍的干预靶点。
- 果糖代谢抑制剂在动物模型中显示出抑制脑乳酸升高和改善认知功能障碍的效果。
局限性
- 患者样本量较小(43例)。
- IL-6相关结果来自小样本亚组。
- 果糖抑制剂效果仅在动物模型中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In elderly individuals, excessive lactate levels in the brain may be associated with the development of cognitive impairment after surgery, including delayed neurocognitive recovery (dNCR). Since the origin of this increased lactate is unknown, here we assessed associations between metabolic pathways and postoperative dNCR. METHODS: This study included 43 patients (≥60 years old) who had surgery under general anesthesia. We also used a mouse model in which 20-month-old mice were exposed to sevoflurane to induce postoperative dNCR, while control mice were exposed to 40% oxygen. Mice in the control group and anesthesia/surgery group were injected with fructose or glucose intracerebroventricularly, or fructose metabolism inhibitor intraperitoneally. Barnes maze test and Y maze were used to measure cognitive function in mice. Metabolomics was used to measure metabolites in the serum of patients and the brains of mice after anesthesia/surgery. Isotope labeling and metabolic flux were used to analyze flow and distribution of specific metabolites in metabolic pathways. RESULTS: Among 43 patients, 17 developed dNCR. Metabolomics showed significantly decreased postoperative serum fructose 1-phosphate levels in dNCR compared to nondNCR patients (mean difference [×10 4 ] = -0.164 ± 0.070; P = .024). Similar results were found in the brains of mice (mean difference = -1.669 ± 0.555; * P = .014). Isotope labeling and metabolic flux experiments in mice showed fructose but not glucose entered glycolysis, increasing lactate levels in the brain after anesthesia/surgery ( P < .05). Administration of intraperitoneal fructose inhibitors to mice effectively inhibited increased lactate levels in the brain (mean difference =96.0 ± 4.36, P = .0237) and cognitive dysfunction after anesthesia/surgery (mean difference =69.0 ± 3.94, P = .0237). In a small subsample, we also found anesthesia/surgery increased interleukin-6 (IL-6) levels in the brains of mice (mean difference =88.3 ± 3.44, P = .0237) and that IL-6 may function upstream in fructose activation. CONCLUSIONS: These results suggest that anesthesia/surgery activates fructose metabolism, producing excessive lactate in the brain that is associated with postoperative cognitive impairment. Fructose metabolism is thus a potential therapeutic target for dNCR.
引用
- Zhang L, Liu J, Miao Z, et al. The Association of Fructose Metabolism With Anesthesia/Surgery-Induced Lactate Production. Anesth Analg. 2024. PMID: 39689012. doi:10.1213/ANE.0000000000007350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。